Recent studies have reported changes in the electroencephalograms (EEG) of patients with major depressive disorder (MDD). However, little research has explored EEG differences between adolescents with MDD and healthy controls, particularly EEG microstates differences. The aim of the current study was to characterize EEG microstate activity in adolescents with MDD and healthy controls (HCs). A total of 35 adolescents with MDD and 35 HCs were recruited in this study. The depressive symptoms were assessed by Hamilton Depression Scale (HAMD) and Children's Depression Inventory (CDI), and the anxiety symptoms were assessed by Chinese version of DSM-5 Level 2-Anxiety-Child scale. A 64-channel EEG was recorded for 5 min (eye closed, resting-state) and analyzed using microstate analysis. Microstate properties were compared between groups and correlated with patients' depression scores. We found increased occurrence and contribution of microstate B in MDD patients compared to HCs, and decreased occurrence and contribution of microstate D in MDD patients compared to HCs. While no significant correlation between depression severity (HAMD score) and the microstate metrics (occurrence and contribution of microstate B and D) differing between MDD adolescents and HCs was found. Adolescents with MDD showed microstate B and microstate D changes. The obtained results may deepen our understanding of dynamic EEG changes among adolescents with MDD and provide some evidence of changes in brain development in adolescents with MDD.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718790PMC
http://dx.doi.org/10.3389/fpsyt.2021.775156DOI Listing

Publication Analysis

Top Keywords

adolescents mdd
24
occurrence contribution
12
contribution microstate
12
mdd
10
microstate
9
adolescents
8
major depressive
8
depressive disorder
8
mdd healthy
8
healthy controls
8

Similar Publications

Prevalence of depressive disorders among pregnant women in Brazil in 2019: A descriptive cross-sectional study.

Sao Paulo Med J

January 2025

Adjunct Professor, Department of General and Specialized Surgery, Faculty of Medicine, Universidade Federal Fluminense (UFF), Niterói (RJ), Brazil.

Background: Prenatal depression threatens maternal and child well-being and interferes with issues prioritized by the 2030 agenda for the Sustainable Development Goals.

Objectives: This study aimed to estimate the prevalence of depressive disorders during pregnancy using the Patient Health Questionnaire-9 (PHQ-9).

Design And Setting: A cross-sectional study using a sample of pregnant Brazilian women, representative of Brazil as a whole.

View Article and Find Full Text PDF

Recovery and Recurrence From Major Depression in Adolescence and Adulthood.

Acta Psychiatr Scand

January 2025

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, and Stockholm Health Care Services, Region Stockholm, Karolinska University Hospital, Stockholm, Sweden.

Article Synopsis
  • The study examined 5-year recurrence rates of first-episode major depressive disorder (MDD) in adolescents and adults, finding rates of 46.1% for adolescents and 49.0% for adults.
  • The research analyzed a large cohort from the Stockholm MDD database, balancing various factors like sex and socioeconomic status to ensure accurate comparisons between the two age groups.
  • Results indicated that there was no significant difference in recurrence likelihood or time to recurrence between adolescents and adults, highlighting the importance of effective relapse prevention strategies across all ages.
View Article and Find Full Text PDF

Background: Previous research has shown that females who use hormonal contraception are at increased risk of developing depression, and that the risk is highest among adolescents. While this finding could reflect age-specific effects of exogenous hormones on mental health, genetic liability for mental disorders could be confounding the association. Our goal was to test the plausibility of this hypothesis by determining whether polygenic liabilities for major depressive disorder (MDD), bipolar disorder (BD), schizophrenia (SCZ), and attention deficit hyperactivity disorder (ADHD) are associated with younger age at hormonal contraception initiation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!